Phase II study of ex vivo expanded cord blood natural killer cells for multiple myeloma.

Nina Shah,Rohtesh S. Mehta,Li Li,Jessica McCarty,Indreshpal Kaur,Robert Z. Orlowski,Laurence J.N. Cooper,Dean Anthony Lee,Kai Cao,Simrit Parmar,Chitra Hosing,Sairah Ahmed,Yago Nieto,Qaiser Bashir,Krina Patel,Catherine M. Bollard,Muzaffar H. Qazilbash,Richard E Champlin,Katayoun Rezvani,Elizabeth J. Shpall

Phase II study of ex vivo expanded cord blood natural killer cells for multiple myeloma.

2018

8006Background: Multiple myeloma (MM) is an incurable disease with immune dysregulation and exhaustion. Remissions in some patients (pts) after allo-stem cell transplant (SCT) suggest a graft versu...

Keywords:

Pathology
Ex vivo
Cancer research
Multiple myeloma
Medicine
Cord blood
Immune dysregulation
Phases of clinical research
Cell
Disease

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations